Go to main content

Message from the CEO

Great Commitment
Great Challenge
Great Company

Our 50-year history has been filled with challenges and commitment. We have persevered over the years with singlehearted dedication toward pain-free, happy lives for all. We have pioneered, and zealously guard our expertise on, plasma and vaccine products. We have insisted on walking only the right paths. We have dealt with every challenge thrown at us with an uncompromising dedication to our mission.

The power of our five decades of existence is what catapults us into the new and global future. We are the No. 1 provider of varicella and seasonal flu vaccines for international organizations.
In the meantime, we have been strengthening and innovating our R&D pipeline.

Our passion, which has kept us going over the years, has prepared us for unrelenting transformation for the next century down the road. Our new website attests to the pride we take in our history, and provides a glimpse into the future we envision for the next five decades.

CEO Eun-chul huh

Eun-chul HuhCEO, GC Biopharma

After obtaining a doctorate in Food Science and Technology from Cornell University, President & CEO Eun-chul Huh began to work At the GC Biopharma R&D Planning Office and Mogam Institute for Biomedical Research. He was able to further augment his experience and expertise in R&D after being appointed Chief Technology Officer (CTO) in 2009. Serving as the Director of the Planning and Coordination Office, overseeing sales, production, and R&D, strengthened his management skills. Since becoming the CEO in 2015, Huh has overseen steady growth in domestic and international sales revenues, and increased strategic investment and R&D capabilities.

이메일집단수집거부

GC녹십자는 이메일 수집을 거부합니다

본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나
그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며,
이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을
유념하시기 바랍니다

게시일: 2003년 9월 1일